Velmie van der Linde

Velmie Van der Linde has a diverse work experience in the pharmaceutical industry. Currently, they hold the position of Head of Oncology at Hetero, starting in March 2022. Prior to this role, they worked at Key Oncologics as an Oncology & Haematology Franchise Manager from August 2020 to September 2021. Additionally, they worked as a Marketing Manager Oncology at AstraZeneca from October 2019 to July 2020, and as a Marketing Manager Oncology & Commercial at Accord Healthcare from June 2017 to September 2019. Velmie also has experience at Lilly, where they held various roles such as SASSA CNS and Cialis Brand Professional, SASSA CNS Brand Manager, CNS Brand Manager, and Cymbalta Brand Manager from 2013 to 2017. Velmie'searlier experiences include roles at Adcock Ingram, where they worked as a Pain Brand Manager, Regional Sales Manager, Product Manager, and Sales Representative from 2004 to 2013.

Velmie Van der Linde began their education in 1994 at the University of Pretoria/Universiteit van Pretoria, where they pursued a Bachelor of Science degree in Physiology. Velmie completed this program in 1999.

In 2008, Velmie enrolled at the IMM Graduate School of Marketing and earned a Bachelor of Business Administration degree in Marketing. Velmie graduated from this program in 2012.

Velmie returned to the IMM Graduate School in 2014 for further studies and completed a Bachelor of Philosophy Honours in Marketing Management degree. Velmie achieved this degree with honors, specializing in Business, Management, Marketing, and Related Support Services. Velmie finished this program in 2016.

Prior to their first degree, Velmie also pursued a Bachelor of Science degree in Human Physiology at the University of Pretoria/Universiteit van Pretoria. Velmie studied in this program from 1993 to 1999.

In 2018, Velmie enrolled at the IMM Graduate School once again, this time for an M Phil degree in Marketing. The end year for this program is not specified.